Literature DB >> 19649425

['Judicialization' of public health policy for distribution of medicines].

Ana Luiza Chieffi1, Rita Barradas Barata.   

Abstract

The supply of medicines in response to court orders or injunctions has become a common practice in the State of São Paulo, Brazil. This 'judicialization' of the health system clashes with basic principles of the Brazilian Unified National Health System (SUS), such as equal opportunity to access health services. The aim of this paper is to analyze the legal action used to obtain medicines through the São Paulo State Health Department, from two main angles: judicialization of public policies and breach of the equity principle. This is a descriptive study of legal action taken to obtain medicines through the São State Health Department, as listed in the Electronic Court Docket System for the year 2006. Most cases were filed through private attorneys; 47% of the patients had obtained their prescriptions through private care; and 73% of the cases involved patients from the three wealthiest areas in the city of São Paulo. The data demonstrate that such legal action violates key principles of the SUS such as equity, thereby privileging individuals with higher purchasing power and more access to information.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19649425     DOI: 10.1590/s0102-311x2009000800020

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  15 in total

1.  The creation of the health consumer: challenges on health sector regulation after managed care era.

Authors:  Celia Iriart; Tulio Franco; Emerson E Merhy
Journal:  Global Health       Date:  2011-02-24       Impact factor: 4.185

2.  Integrality of the therapeutic and pharmaceutical care: a necessary debate.

Authors:  Fabiola Sulpino Vieira
Journal:  Rev Saude Publica       Date:  2017-12-11       Impact factor: 2.106

3.  Phosphoethanolamine and the danger of unproven drugs.

Authors:  Noam Pondé; Evandro de Azambuja; Felipe Ades
Journal:  Ecancermedicalscience       Date:  2016-10-17

4.  Judicial demand of medications through the Federal Justice of the State of Paraná.

Authors:  Renato Mitsunori Nisihara; Ana Carolina Possebom; Luiza de Martino Cruvinel Borges; Ana Claudia Athanasio Shwetz; Fernanda Francis Benevides Bettes
Journal:  Einstein (Sao Paulo)       Date:  2017 Jan-Mar

5.  Realizing the right to health in Brazil's Unified Health System through the lens of breast and cervical cancer.

Authors:  Fabiana da Mota Almeida Peroni; Magnus Lindelow; David Oliveira De Souza; Mirja Sjoblom
Journal:  Int J Equity Health       Date:  2019-06-03

6.  Adherence to guidelines in the use of biological agents to treat psoriasis in Brazil.

Authors:  Miriam Sanches do Nascimento Silveira; Iara Alves de Camargo; Claudia Garcia Serpa Osorio-de-Castro; Silvio Barberato-Filho; Fernando de Sá Del Fiol; Gordon Guyatt; Mayara Costa de Camargo; Luciane Cruz Lopes
Journal:  BMJ Open       Date:  2014-03-05       Impact factor: 2.692

7.  Evaluation of the Capillary Blood Glucose Self-monitoring Program.

Authors:  Mariana Cristina Augusto; Maria José Trevizani Nitsche; Cristina Maria Garcia de Lima Parada; Maria Lúcia Zanetti; Maria Antonieta de Barros Leite Carvalhaes
Journal:  Rev Lat Am Enfermagem       Date:  2014-10

8.  The Judicialization of Health and the Quest for State Accountability: Evidence from 1,262 Lawsuits for Access to Medicines in Southern Brazil.

Authors:  João Biehl; Mariana P Socal; Joseph J Amon
Journal:  Health Hum Rights       Date:  2016-06

Review 9.  Prioritization of strategies to approach the judicialization of health in Latin America and the Caribbean.

Authors:  Carlos Eduardo Pinzón-Flórez; Evelina Chapman; Leonardo Cubillos; Ludovic Reveiz
Journal:  Rev Saude Publica       Date:  2016-09-01       Impact factor: 2.106

10.  Legal access to medications: a threat to Brazil's public health system?

Authors:  Ana Luiza Chieffi; Rita De Cassia Barata Barradas; Moisés Golbaum
Journal:  BMC Health Serv Res       Date:  2017-07-19       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.